Skip to main content

News 2023

Newborn brain screener from UCC spin-out company CergenX awarded €6.7 million funding

28 Nov 2023
Sean Griffin, CTO; Professor Geraldine Boylan, CSO; and Jason Mowles, CEO of CergenX

A new technology to screen newborns for brain injury has been awarded €6.7million in funding from the Disruptive Technology Innovation Fund (DTIF). The major investment will support scientists and engineers to advance brain health monitoring for newborn babies. The Irish Centre for Maternal and Child Health Research (INFANT) at University College Cork with UCC spin-out CergenX and Evervault were awarded €6.7million for the Newborn Brain Screener (NBS) project which will develop a novel platform to detect abnormal brain activity in infants soon after birth through an automated AI assessment.

Research and Innovation

Taighde agus Nuálaíocht

Office of Vice President for Research & Innovation 4th Floor Block E, Food Science Building UCC,

Top